Study identifies hypertension patients who can benefit from the little used diuretic amiloride

August 19, 2002

Bethesda, Md. (August 13, 2002) -- Hypertension is a common disorder with potentially devastating complications that disproportionately affects the black community. It accounts for approximately 25 percent of all cases of end stage renal disease in the African-American population. Since patients have no symptoms, it frequently goes undiagnosed. Excellent treatments are available; however, given that it is a chronic disease and that patients are asymptomatic, keeping patients on treatment can be difficult. The African American Study of Kidney Disease and Hypertension (AASK) has shown that hypertension can be successfully treated in this population, leading to the reduction in the rate of deterioration of kidney function, according to Denyse Thornley-Brown, M.D., Assistant Professor of Medicine at the University of Alabama at Birmingham and a co-principal investigator of the AASK trial.

Tied To Slave Ship Transport?
There is an intriguing hypothesis enumerated by Clarence E. Grim, M.D., from the Medical College of Wisconsin, Division of Cardiovascular Medicine, which may help to explain the high incidence of hypertension in African Americans. When Africans were transported to the Americas, they were sailed across an equatorial ocean. They were not fed, and they were given little or no water. Consequently, a high percentage of individuals died in transit. This could be thought of an unnatural selection process. As a direct result of this occurrence, the survivors are thought to be individuals that could retain salt and water most efficiently. To put it another way, the people that survived needed very little salt. Circumstances with respect to salt availability have changed. Today salt is ubiquitous, and thus, the overexposure to salt by individuals with a high salt retentive capacity may be one reason for the elevated blood pressures observed today in the descendants of these original survivors.

The Study
Recently, a team of Alabama researchers, led by James K. Bubien Ph.D., has utilized state of the art electrophysiological technology to identify individuals with a specific salt retentive disorder causing their hypertension, and to remove any uncertainty for individual patients. The authors of "Hyperactive ENaC Identifies Hypertensive Individuals Amenable to Amiloride Therapy," are Artensie R. Carter, Zhen Hong Zhou, David A. Calhoun, and James K. Bubien, all from the University of Alabama at Birmingham, Birmingham, AL. Their findings have recently been published in the American Journal of Physiology - Cell Physiology, a publication of the American Physiological Society (APS).

Background
Amiloride is a potassium-sparing diuretic (water pill), most often used to treat edema (swelling), thereby reducing the amount of fluid in the body without causing the loss of potassium. Some individuals with hypertension have benefited from this medication. However, identifying which patients will or will not benefit from this therapy has been difficult. Until now.

Inappropriate retention of salt water can lead to hypertension (high blood pressure). There is a powerful mechanism in the kidney designed to retain salt and water during times of high loss, such as heavy exercise, sustained heat and humidity, or water deprivation. If this control of this mechanism is not precise, excessive salt and water can be reabsorbed, leading to elevation of blood pressure. The high prevalence of high blood pressure that tends to run in African Americans families, and the discovery of mutations in the main protein responsible for this specific salt retaining mechanism have led researchers at the University of Alabama at Birmingham to consider the possibility that gene changes or other factors that regulate this process and this protein may underlie the high incidence of hypertension in African Americans. Awareness of this possibility is important because of the devastating health consequences to the African American community.

Methodology
The initial step was an assessment of whether peripheral blood lymphocytes expressing ENaC (epithelial Na+ channels) similar to the same expressed by renal cells could be linked to hypertensive etiologies. The second was to test the hypothesis that specific inhibition of hyperactive ENaC with amiloride could improve hypertension.

To test their assumption, the researchers obtained blood samples from patients with normal blood pressure and hypertensive patients. Volunteers were between ages 19 and 70 and were recruited from the University of Alabama-Birmingham Hypertension Clinic. Blood samples were taken from subjects diagnosed as normotensive (unmedicated blood pressure <140>140/90 mmHg despite ongoing therapy with three or more anti-hypertensive agents). Nine subjects with refractory hypertension were prescribed amiloride for a four-week period.

Subjects were assessed after two weeks and their dosage increased to five milligrams, twice daily. Lymphocytes were examined to determine whether ENaC was hyperactive. They were then divided into four samples and frozen at -84°C before undergoing electrophysiological examination. A determination of normal or abnormal ENaC regulation was based on the basal channel activity and a response to cyclic AMP. Blood pressure was compared before and after treatment.

Results
Cells from blood samples of 106 volunteers were examined using a whole cell patch clamp (a technique used in the study of ion channels in which the movement of ions across a small patch of isolated membrane is measured when the membrane is electrically polarized or hyperpolarized and maintained at that potential). The researchers found:Conclusions
This study best exemplifies the potential benefits of translational physiology, demonstrating that research performed in the laboratory has immediate benefits to the diagnosis and treatment of a wide range of chronic disorders that afflict Americans.

Presently, amiloride is not considered a first-option treatment for hypertensive patients. These findings will enable caregivers to target those patients who suffer from this deadly condition that will benefit from pharmaceutical products now available.

Findings Have High Impact for Research Overall
This research marks a new direction in physiology research. These investigators adhered to the principles of translational physiology, known as the transfer of knowledge gained from basic research to new and improved methods of preventing, diagnosing, or treating disease, as well as the transfer of clinical insights into hypotheses that can be tested and validated in the basic research laboratory. This process occurs from the bench to the bedside, as well as from the bedside back to the bench.

It is highly suitable for the post-genomic era, enabling physiologists to interact with other basic scientists, engineers, bioinformatics experts, and clinicians in translating the wealth of genetic and molecular information into a better understanding of how the human body functions in health and disease.
-end-
Source: American Journal of Physiology - Cell Physiology

The American Physiological Society (APS) was founded in 1887 to foster basic and applied science, much of it relating to human health. The Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals every year.

American Physiological Society

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.